Hannah Valantine sold $1.0M of CareDx (CDNA)

Executed Jul 16, disclosed Jul 17, 1 day later.

Value, as filed

$1.0M

28,679 sh × $36.14

Executed

Jul 16

the trade date, as filed

Disclosed

Jul 17

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Hannah Valantine Director profile →

Hannah Valantine (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $1.7M of BBIO (25,484 sh across 2 lots, as filed), executed Feb 27.

The name

CDNA

CareDx, Inc. CDNA · Healthcare · 26 filings in 24 months ticker →

Healthcare · CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internat…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Hannah Valantine in CDNA

CDNASALE CareDx, Inc. $280K
12,103 sh × $23.11
Exec Jun 15
Filed Jun 16 · 5:30 PM ET CDNASALE CareDx, Inc. $203K
10,570 sh × $19.16
Exec Jun 18 2025
Filed Jun 23 2025 · 5:30 PM ET